Farmers & Merchants Investments Inc. Cuts Stock Position in Kenvue Inc. $KVUE

Farmers & Merchants Investments Inc. cut its holdings in Kenvue Inc. (NYSE:KVUE) by 4.7% in the second quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 70,435 shares of the company’s stock after selling 3,475 shares during the quarter. Farmers & Merchants Investments Inc.’s holdings in Kenvue were worth $1,474,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Pittenger & Anderson Inc. purchased a new position in Kenvue during the first quarter worth $30,000. TruNorth Capital Management LLC purchased a new position in Kenvue during the first quarter worth $36,000. Truvestments Capital LLC purchased a new position in Kenvue during the first quarter worth $37,000. Clal Insurance Enterprises Holdings Ltd boosted its stake in Kenvue by 378.5% during the first quarter. Clal Insurance Enterprises Holdings Ltd now owns 1,627 shares of the company’s stock worth $39,000 after buying an additional 1,287 shares during the period. Finally, Bank Julius Baer & Co. Ltd Zurich boosted its stake in Kenvue by 120.6% during the first quarter. Bank Julius Baer & Co. Ltd Zurich now owns 1,699 shares of the company’s stock worth $41,000 after buying an additional 929 shares during the period. 97.64% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several research analysts have commented on KVUE shares. Barclays dropped their price objective on shares of Kenvue from $23.00 to $22.00 and set an “equal weight” rating for the company in a research note on Tuesday, July 15th. JPMorgan Chase & Co. dropped their price objective on shares of Kenvue from $27.00 to $26.00 and set an “overweight” rating for the company in a research note on Friday, July 25th. Zacks Research upgraded Kenvue to a “strong sell” rating in a research report on Monday, August 11th. Royal Bank Of Canada decreased their target price on Kenvue from $24.00 to $22.00 and set a “sector perform” rating for the company in a research report on Friday, August 8th. Finally, Evercore ISI decreased their target price on Kenvue from $25.00 to $23.00 and set an “in-line” rating for the company in a research report on Monday, September 8th. Five investment analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Hold” and a consensus price target of $24.04.

Kenvue Price Performance

Shares of KVUE stock opened at $16.96 on Tuesday. Kenvue Inc. has a fifty-two week low of $16.89 and a fifty-two week high of $25.17. The firm has a market capitalization of $32.55 billion, a price-to-earnings ratio of 22.92, a PEG ratio of 2.63 and a beta of 0.83. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.68 and a current ratio of 0.98. The stock’s 50-day simple moving average is $20.77 and its 200-day simple moving average is $22.00.

Kenvue (NYSE:KVUE) last issued its quarterly earnings results on Thursday, August 7th. The company reported $0.29 earnings per share for the quarter, topping analysts’ consensus estimates of $0.28 by $0.01. Kenvue had a return on equity of 20.06% and a net margin of 9.37%.The business had revenue of $3.84 billion for the quarter, compared to analyst estimates of $3.94 billion. During the same quarter in the previous year, the firm earned $0.32 earnings per share. The company’s revenue was down 4.0% on a year-over-year basis. Kenvue has set its FY 2025 guidance at 1.000-1.050 EPS. As a group, equities analysts forecast that Kenvue Inc. will post 1.14 earnings per share for the current fiscal year.

Kenvue Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, August 27th. Investors of record on Wednesday, August 13th were given a $0.2075 dividend. This is an increase from Kenvue’s previous quarterly dividend of $0.21. This represents a $0.83 dividend on an annualized basis and a yield of 4.9%. The ex-dividend date was Wednesday, August 13th. Kenvue’s payout ratio is currently 112.16%.

Kenvue Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.